Search Results: ind (6008)

The vast possibilities of hemp are emerging as the legal barriers to hemp-based products begin to disappear, and among those possibilities is manufacturing products not for consumers, but for other companies. While many businesses involved with hemp and CBD are eager for the spotlight, others would rather do their work without the attention, in exchange for a manufacturing fee.

To learn more about the cannabis industry’s white-label products — something produced by one company for another to rebrand and sell — we talked with Maruchy Lachance, co-owner of CBD white-label company Boulder Botanical & Bioscience Laboratory.

Cannabis has become a popular alternative treatment for cancer, but with one of its own fighting for his life, the legal pot industry has geared up to fight the disease on a different level. A member of that industry for five years, Jason Margolies was diagnosed with stage-four colon cancer at the beginning of 2018.

Suffering from Crohn’s disease since at least 2000, Margolies considered himself lucky to have never required surgery, but that changed last fall when his health began to decline. An operation found a tumor in his chest; initially labeled benign, it was actually malignant. In January, doctors found that cancer had spread to his lungs and abdomen.

The legal marijuana industry is booming, according to a new report from one of commercial pot’s largest job recruiters. But which jobs are paying the most?

In a recent analysis of the marijuana industry’s job and salary rates, Vangst, the self-proclaimed “Monster.com of the cannabis industry,” says it expects pot industry employment to see an annual growth of 220 percent in 2019. Using previously compiled data and a survey of over 1,200 marijuana companies, Vangst reports that salaries at licensed pot businesses (those directly touching the plant) grew over 16 percent in 2018, with industry job listings increasing by nearly 700 percent during a seven-month period between January and August.

Although Colorado’s legal cannabis industry has maintained a steady of pace of increasing revenues over the years, a new market report from one of pot’s leading economic-research teams says it could be time to prepare for a plateau.

In BDS Analytics and Arcview’s sixth annual State of Legal Marijuana Markets report, the two cannabis firms dive into each state with medical or recreational cannabis programs. Arcview, known for its investment and market research, notes that it’s never had so many states to cover in its report — and all that new competition will likely draw tourist buyers into new regions as they come online, including Nevada, California, Massachusetts, Canada and possibly Maine.

CBD products are touted for their healing properties. But even they would have a hard time mending the rift that’s torn apart a Colorado CBD company, which has dissolved amid dueling lawsuits, with one alleging a scheme to funnel more than $1 million to an animal sanctuary in Costa Rica and the other focusing on $300,000 in missing meds and a series of accused co-conspirators, one of whom is named Natalia Swindler.

At the center of this drama is John Merritt, the man behind Full Spectrum Nutrition Inc., a Colorado Springs operation that’s currently in limbo.

A new analysis finds that while marijuana legalization has led to higher rates of cannabis consumption in Colorado and other states with similar laws, there’s no evidence that it’s fueling abuse of more addictive drugs, including heroin and cocaine.

That’s the conclusion of a just-issued report from LiveStories, which specializes in the analysis of civic data. LiveStories founder Adnan Mahmud summarizes the results like so: “We haven’t found any strong correlation that suggests increased marijuana use leads to increases in other substance abuse.”

Members of Congress joined legal cannabis-industry representatives in front of the United States Capitol today, May 23, calling for an end to federal pot prohibition. Among the lawmakers appearing in solidarity with the National Cannabis Industry Association were Colorado representatives Diana DeGette and Jared Polis.

“There are 34,000 Coloradans who are licensed to work in this industry, so you can imagine how dismayed everyone in Colorado was when Attorney General Jeff Sessions announced he was going to rescind the Cole Memo,” DeGette told the gathering. “I can say, I have never seen our delegation work so quickly to fix something in a bipartisan way.”

The state’s hemp industry, which produces the majority of cannabidiol (CBD) products in Colorado, are worried about the consequences of a bill the General Assembly has approved that opens the door for CBD medicine approved by the United States Food and Drug Administration.

Colorado lawmakers wanted to be ahead of the curve with HB 1187, introduced by State Representative Janet Buckner, to allow a pharmaceutical drug made from CBD that is expected to receive FDA approval within the next couple of months to be sold in Colorado. That drug, Epidiolex, is made by an American subsidiary of British GW Pharmaceuticals for treating epilepsy.

A new study of Colorado’s legal cannabis industry found that most of its employees were high on their jobs, but also concluded that a sizable portion of those employees were high at their jobs.

Conducted by the Colorado State University Department of Psychology and published in the American Journal of Industrial Medicine, the project surveyed around 200 cannabis employees at companies along the Front Range that work directly with the plant, and the results are surprisingly candid.

1 2 3 4 5 6 601